# Prepulse Inhibition (PPI) of Startle Reflex in Schizophrenia Patients Related to Type of Treatment and Illness Duration

> **NCT02484521** · NA · COMPLETED · sponsor: **HaEmek Medical Center, Israel** · enrollment: 31 (actual)

## Conditions studied

- Inhibition (Psychology)
- Schizophrenia
- Medication Adherence

## Interventions

- **DEVICE:** PPI monitoring device protocol
- **OTHER:** Questionnaires

## Key facts

- **NCT ID:** NCT02484521
- **Lead sponsor:** HaEmek Medical Center, Israel
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-06
- **Primary completion:** 2019-06
- **Final completion:** 2019-06
- **Target enrollment:** 31 (ACTUAL)
- **Last updated:** 2020-02-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02484521

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02484521, "Prepulse Inhibition (PPI) of Startle Reflex in Schizophrenia Patients Related to Type of Treatment and Illness Duration". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT02484521. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*